Clara Suñer

ORCID: 0000-0003-2581-8864
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Poxvirus research and outbreaks
  • Herpesvirus Infections and Treatments
  • Bacillus and Francisella bacterial research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • RNA Research and Splicing
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Syphilis Diagnosis and Treatment
  • Reproductive tract infections research
  • SARS-CoV-2 detection and testing
  • Infection Control and Ventilation
  • Biosensors and Analytical Detection
  • Immune cells in cancer
  • Health disparities and outcomes
  • Geriatric Care and Nursing Homes
  • Adolescent Sexual and Reproductive Health
  • Sexual function and dysfunction studies
  • Vitamin C and Antioxidants Research
  • Travel-related health issues
  • Yersinia bacterium, plague, ectoparasites research
  • Rabies epidemiology and control
  • COVID-19 epidemiological studies
  • Autophagy in Disease and Therapy

Manhiça Health Research Centre
2025

Universitat de Barcelona
2025

Barcelona Institute for Global Health
2025

Fundació Lluita contra les Infeccions
2020-2024

Hospital Universitari Germans Trias i Pujol
2022-2024

Universitat Autònoma de Barcelona
2023-2024

Fundació ACE
2024

Universitat de Vic - Universitat Central de Catalunya
2023

Red de Investigación en Sida
2023

Institute for Research in Biomedicine
2020-2022

<h2>Summary</h2><h3>Background</h3> In May, 2022, several European countries reported autochthonous cases of monkeypox, which rapidly spread globally. Early reports suggest atypical presentations. We aimed to investigate clinical and virological characteristics human monkeypox in Spain. <h3>Methods</h3> This multicentre, prospective, observational cohort study was done three sexual health clinics Madrid Barcelona, enrolled all consecutive patients with laboratory-confirmed from May 11 June...

10.1016/s0140-6736(22)01436-2 article EN cc-by The Lancet 2022-08-01
Natàlia Casamitjana Andrea Alemany Michael Marks Jezer I Lezama Mora Juan Carlos Rodríguez‐Aldama and 95 more Mayara Secco Torres Silva Ever Arturo Corral Herrera Brenda Crabtree‐Ramírez José Luís Blanco Nicolò Girometti Valentina Mazzotta Aniruddha Hazra Macarena Silva Juan José Montenegro-Idrogo Kelly A. Gebo Jade Ghosn María Fernanda Peña Vázquez Eduardo Matos Prado Uche Unigwe Judit Villar-García Noah Wald‐Dickler Jason Zucker Roger Paredes Alexandra Calmy Laura Waters Cristina Galván‐Casas Sharon Walmsley Chloe Orkin Viviana Leiro Lucila Marchetta Patricia Fernandez Pardal María Inés Figueroa Pedro Cahn Katharina Grabmeier‐Pfistershammer Agnès Libois Laurens Liesenborghs Beatriz Grinsztejn Mauro Schechter Alberto dos Santos de Lemos Alvaro Furtado Costa Simone Queiroz Rocha José Valdez Madruga Darrell H. S. Tan Sharmistha Mishra Shreya Shah Camila Jorquera Alberto Castillo Mauricio Carrión Nelson Salas Romain Palich Valérie Pourcher Emma Rubenstein Pascal Migaud Christoph Boesecke Christian Hoffmann Konstantinos Protopapas Silvia Nozza Anna Maria Cattelan Cristina Mussini Antonella d’Arminio Monforte Raúl Adrian Cruz Flores Edgar Pérez‐Barragán Alma Leticia Rodríguez Guzmán Dimie Ogoina Nneka Marian Chika-Igwenyi Chizaram Onyeaghala Jenny Valverde López Angelica García Tello María Ubals Martí Vall Adrià Mendoza Clara Suñer Bonaventura Clotet Jordi Bechini José Antonio Lepe Ma Dolores Navarro-Amuedo José I Bernadino Alba Català Eloy José Tarín Vicente Borja González Rodríguez Sergi Rodríguez-Mercader Francisca Sánchez-Martinez Esperanza Cañas‐Ruano Laura Parra‐Navarro Finn Filén Carmen Tallón de Lara Dominique L. Braun Vanja Piezzi M. Burkhard Helen Kovari Anja Mönch Jake Dunning Pedro Simoes Achyuta Nori Sarah S. Keegan John Thornhill Vanessa Apea Teymur Noori Joyce Jones Seth Judson

10.1016/s0140-6736(23)00273-8 article EN The Lancet 2023-02-22

No effective treatments for coronavirus disease 2019 (COVID-19) exist. We aimed to determine whether early treatment with hydroxychloroquine (HCQ) would be efficacious outpatients COVID-19.Multicenter open-label, randomized, controlled trial conducted in Catalonia, Spain, between 17 March and 26 May 2020. Patients recently diagnosed <5-day of symptom onset were assigned receive HCQ (800 mg on day 1 followed by 400 once daily 6 days) or usual care. Outcomes reduction viral load nasopharyngeal...

10.1093/cid/ciaa1009 article EN other-oa Clinical Infectious Diseases 2020-07-13

BackgroundCurrent strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions. Hydroxychloroquine has been proposed as a postexposure therapy prevent disease 2019 (Covid-19), but definitive evidence is lacking.MethodsWe conducted an open-label, cluster-randomized trial involving asymptomatic contacts of patients with polymerase-chain-reaction (PCR)–confirmed Covid-19 in Catalonia, Spain. We randomly assigned...

10.1056/nejmoa2021801 article EN New England Journal of Medicine 2020-11-24
Andrea Alemany Pere Millat-Martínez Marc Corbacho-Monné Pierre Malchair Dan Ouchi and 95 more Anna Ruiz‐Comellas Anna Ramírez‐Morros Joana Rodríguez Codina Rosa Amado Simon Sebastián Videla Gèlia Costes Mar Capdevila-Jáuregui Pamela Torrano-Soler Alba San José Glòria Bonet Papell Jordi Puig Aurema Otero José Carlos Ruibal Suárez Alvaro Zarauza Pellejero Ferrán Llopis Roca Orlando Rodriguez Cortez Vanesa García García Josep Vidal‐Alaball Anna Millán Enric Contreras Joan-Ramon Grífols Águeda Ancochea Iván Galván‐Femenía Francini Piccolo Ferreira Mireia Bonet Jordi Cantoni Núria Prat Jordi Ara Anna Forcada Arcarons Magı́ Farré Edwards Pradenas Julià Blanco Miquel Ángel Rodríguez-Arias Gema Fernández Rivas Michael Marks Quique Bassat Ignacio Blanco Bàrbara Baró Bonaventura Clotet Natàlia Casamitjana Susana Ferrer Mireia Gallardo María Ubals Camila González-Beiras Martí Vall-Mayans Clara Suñer Clàudia Laporte-Villar Aroa Nieto Xavier Comas-Leon Z. Abad Jiménez Ferran Ramírez-Viaplana Maria Delgado-Capel Beatriz Sánchez Maria Pons Barber Cristian Gonzalez Ruiz Laura Navarrete Gonzalez David González García Ainhoa Vivero Larraza Victor Carceles Peiró Clàudia Roquer López Neus Robert Carles Palet Carlota Gudiol Pablo Casares Gonzalez Gemma Arcos Vila Begoña Flores Aguilera Graciela Rodríguez-Sevilla Macarena Dastis Arias Judit Roca Font Katherine M. Carrasco Matos Glòria Saüch Valmaña Carla Vidal Obradors Silvia Tarres García Margarida Curriu Sabatès Raquel Nieto Rodríguez Rosa Línio Míriam Fornos Natàlia Casamitjana E Fernández Alonso Núria Martínez Laura Analía Maglio Laura Comellas Fernandez Nadia L. González García Luis Hernández Maria Gonzalez A. Palomo Bravo Yolanda García García Sílvia Sauleda Tatiana Vertiz Sergio Benavent Andrea Sofia Bianco Joaquim Verdaguer Ney Nicanor Briones Zambrano Maria Viozquez Meya Águeda Hernández

10.1016/s2213-2600(21)00545-2 article EN The Lancet Respiratory Medicine 2022-02-09

We investigated mechanisms of hepatic stellate cell (HSC) activation, which contributes to liver fibrogenesis. aimed determine whether activated HSCs increase glycolysis, is regulated by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3), and this pathway might serve as a therapeutic target.We performed studies with primary mouse HSCs, human LX2 cirrhotic tissues, rats mice fibrosis (due bile duct ligation [BDL] or administration carbon tetrachloride), CPEB4-knockout mice....

10.1053/j.gastro.2020.03.008 article EN cc-by-nc-nd Gastroenterology 2020-03-11

BackgroundThe increasing incidence of syphilis and the limitations first-line treatment with penicillin, particularly in neurosyphilis, neonatal syphilis, pregnancy, highlight need to expand therapeutic repertoire for effective management this disease. We assessed in-vitro efficacy 18 antibiotics from several classes on Treponema pallidum subspecies (T pallidum), bacteria.MethodsUsing culture system T pallidum, we exposed pathogen a concentration range each tested antibiotic. After 7-day...

10.1016/s2666-5247(23)00219-7 article EN cc-by-nc-nd The Lancet Microbe 2023-10-09

Many countries have resumed mass-gathering events like music festivals, despite the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreading. In this study, we aimed to assess effect two outdoor events, held during a peak SARS-CoV-2 transmission, on COVID-19 incidence.This was retrospective, population-based control-matched analysis. The study population included attendees festivals in Catalonia (North-East Spain). primary objective compare incidence within 3-to-10 days...

10.1016/j.lanepe.2022.100337 article EN cc-by The Lancet Regional Health - Europe 2022-02-28

Management of syphilis, a sexually transmitted infection (STI) with increasing incidence, is challenged by drug shortages, scarcity randomised trial data, an absence non-penicillin alternatives for pregnant women penicillin allergy (other than desensitisation), extended parenteral administration neurosyphilis and congenital macrolide resistance. Linezolid was shown to be active against Treponema pallidum, the causative agent in vitro rabbit model. We aimed assess efficacy linezolid treating...

10.1016/s1473-3099(23)00683-7 article EN cc-by-nc-nd The Lancet Infectious Diseases 2024-01-08

ABSTRACT Background Current strategies for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections are limited to non-pharmacological interventions. Hydroxychloroquine (HCQ) has been proposed as a postexposure therapy prevent Coronavirus disease 2019 (Covid-19) but definitive evidence is lacking. Methods We conducted an open-label, cluster-randomized trial including asymptomatic contacts exposed PCR-positive Covid-19 case in Catalonia, Spain. Clusters were...

10.1101/2020.07.20.20157651 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-07-26

Chronic inflammation is a major cause of disease. Inflammation resolution in part directed by the differential stability mRNAs encoding pro-inflammatory and anti-inflammatory factors. In particular, tristetraprolin (TTP)-directed mRNA deadenylation destabilizes AU-rich element (ARE)-containing mRNAs. However, this mechanism alone cannot explain variety expression kinetics that are required to uncouple degradation from sustained Here, we show RNA-binding protein CPEB4 acts an opposing manner...

10.7554/elife.75873 article EN cc-by eLife 2022-04-20

The pathophysiology of viral diseases is complex, and often evokes strong inflammatory responses tissue damage. Currently available in vitro models mainly recapitulate the life cycle per se, but fail to model immune cell-mediated pathogenesis. Here we build macrophage-augmented organoids (MaugOs) by integrating macrophages into that are cultured from human liver tissues. We test infections two RNA viruses, hepatitis E virus (HEV) SARS-CoV-2, one DNA virus, monkeypox (MPXV), which either...

10.1101/2025.02.27.25322840 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-03-03

Background: The MVA-BN vaccine is considered effective for preventing mpox in key populations, based on observational studies, though its effectiveness remains unconfirmed by randomized trials. Observational studies published to date rely retrospective analyses of routine data, often missing information relevant risk factors mpox. Methods: Multi-country target trial emulation study with prospective data collection. Between September 1, 2022, and June 15, 2023, we recruited individuals...

10.20944/preprints202504.2096.v1 preprint EN 2025-04-24

Background:,Monkeypox DNA has been detected in skin lesions, saliva, oropharynx, urine, semen, and stool of patients infected during the 2022 outbreak; however, viral dynamics within these compartments remain unknown. We investigated clearance over course illness.Methods: This was an observational, prospective, multicentre study including individuals diagnosed with monkeypox hospitals sexual health clinics Spain. Participants collected swabs from their rectum, a dried blood spot, either...

10.2139/ssrn.4248017 article EN SSRN Electronic Journal 2022-01-01

Upon tissue injury, cytokine expression reprogramming transiently remodels the inflammatory immune microenvironment to activate repair processes and subsequently return homeostasis. However, chronic inflammation induces permanent changes in production which exacerbate damage may even favor tumor development. Here, we address contribution of post-transcriptional regulation, by RNA-binding protein CPEB4, intestinal homeostasis its role bowel diseases (IBD) colorectal cancer (CRC) We found that...

10.1016/j.isci.2022.103790 article EN cc-by-nc-nd iScience 2022-01-22

Background Evidence on the determinants of magnitude humoral responses and neutralizing titers in individuals with mild COVID-19 is scarce. Methods In this cohort study patients, we assessed viral load (VL) by RT-qPCR at two/three time points during acute infection, anti-SARS-CoV-2 antibodies ELISA plasma using a pseudovirus assay day 60. Results Seventy-one (65% female, median 42 years old) were recruited grouped into high &amp;gt;7.5 Log 10 copies/mL (n=20), low, VL ≤7.5 (n=22), or as...

10.3389/fimmu.2022.860215 article EN cc-by Frontiers in Immunology 2022-04-28

Despite use of tecovirimat since the beginning 2022 outbreak, few data have been published on its antiviral effect in humans. We here predict efficacy using a unique set nonhuman primates (NHPs) and analyzed activity viral kinetics NHP to characterize concentration-effect relationship vivo. Next, we used pharmacological model developed healthy volunteers project Finally, dynamic was applied mpox skin lesions from 54 untreated patients, this modeling framework impact clearance lesions. At...

10.1371/journal.pbio.3002249 article EN cc-by PLoS Biology 2023-12-21
Coming Soon ...